SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-22-049149
Filing Date
2022-09-08
Accepted
2022-09-08 16:15:47
Documents
2
Period of Report
2022-09-06

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1694
2 POA DOCUMENT poa.txt EX-24 3637
  Complete submission text file 0001209191-22-049149.txt   6644
Mailing Address 400 CROSSING BOULEVARD 3RD FLOOR BRIDGEWATER NJ 08807
Business Address (908) 947-3120
Amneal Pharmaceuticals, Inc. (Issuer) CIK: 0001723128 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 4 PARK LANE MADISON NJ 07940
Business Address
Pesquin Gustavo (Reporting) CIK: 0001944691 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38485 | Film No.: 221233978